Pelthos Therapeutics Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Pelthos Therapeutics Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Tangible Net Worth Ratio: Goodwill and other intangibles are larger than its whole net worth, so its tangible net worth is negative. Less tangible than 90% of Healthcare companies in United States.
- Steadiness Ratio: Sales grew in 1 of the last 3 years; profit grew in 0 of 3. Less steady than 86% of Healthcare companies in United States.
- Shareholder Slice Ratio: Share count rose 461% in 3 years, so each share's slice of the company became smaller. Bigger rise in share count than 85% of Healthcare companies in United States.
Where $100 of sales goes
Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
—Data incomplete
Cash Locked Ratio
—Data incomplete
Growth quality
Steadiness Ratio
1/3 · 0/3Sales grew in 1 of the last 3 years; profit grew in 0 of 3.
Less steady than 86% of Healthcare companies in United States.
Growth Efficiency Ratio
—Data incomplete
Asset Productivity Ratio
—Data incomplete
Balance-sheet strength
Debt Due Cover Ratio
-35.6×Operating cash was negative last year, while some debt falls due within a year.
Lower than 66% of Healthcare companies in United States.
Cash Cushion Ratio
−22%Debt, after subtracting cash, equals 22% of its market value (net debt).
Lower than 85% of Healthcare companies in United States.
Tangible Assets Ratio
51%Of every $100 the company owns, $51 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
Less tangible than 79% of Healthcare companies in United States.
Tangible Net Worth Ratio
NegativeGoodwill and other intangibles are larger than its whole net worth, so its tangible net worth is negative.
Less tangible than 90% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (10)
Pelthos Therapeutics Inc. made a loss over the last year. Pelthos Therapeutics Inc. owes $1.01 for every $1 it owns. Pelthos Therapeutics Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossPelthos Therapeutics Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
-49.97Pelthos Therapeutics Inc.'s book value is negative (it owes more than it owns), so P/B is not meaningful.
Market cap
$75 MThe total market value of all of Pelthos Therapeutics Inc.'s shares at today's price (share price × number of shares), smaller than 69% of Healthcare companies in United States. PosiCap size class: Micro Cap.
Net worth (book value)
NegativePelthos Therapeutics Inc.'s net worth is negative ($2 M below zero, balance sheet 30 Jun 2026): it owes more than it owns, so book value per share and P/B are not meaningful.
Owes vs Owns
1.01×Pelthos Therapeutics Inc. owes $1.01 for every $1 it owns, so it owes more than it owns, higher than 87% of Healthcare companies in United States.
Dividend yield
NonePelthos Therapeutics Inc. does not currently pay a dividend.
Profit growth
LossPelthos Therapeutics Inc. made a loss in each of the last two years.
Profit margin
-257.9%Pelthos Therapeutics Inc. lost $258 for every $100 of revenue.
Interest cover
Not coveredPelthos Therapeutics Inc.'s operating profit did not cover its interest costs in the year to Dec 2025.
Cash vs debt
Net debtPelthos Therapeutics Inc. had $17 M more debt than cash (net debt) at Dec 2025.
Questions
How much does Pelthos Therapeutics Inc. owe compared with what it owns?
Pelthos Therapeutics Inc. owes $1.01 for every $1 it owns, so it owes more than it owns, higher than 87% of Healthcare companies in United States.
Does Pelthos Therapeutics Inc. pay a dividend?
No. Pelthos Therapeutics Inc. does not currently pay a dividend.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.